モバイルヘルス（mHealth）の世界市場-2022-2029

市場力学

ヘルスケアに対する意識の高まり、利便性によるスマートフォンやタブレット端末の利用拡大、個別化医療への注目の高まりが、世界のモバイルヘルス市場を牽引しています。

モバイルヘルス（mHealth）が提供するメリットと利便性が、市場の成長を後押ししています。

モバイルヘルスによって提供される利点と利便性が、世界市場の成長を後押ししています。例えば、モバイルヘルス技術は、患者が安全なメッセージを素早く送信したり、予約を入れたり、遠隔医療を受けるために24時間いつでも接続できるようにします。特に、遠隔医療は、患者がモバイルデバイスでmヘルスアプリを使用する方法の中でも、最も急速に成長している方法です。また、自動投薬・補充リマインダーや教育情報など、患者さんが適切に薬を服用する可能性を高める機能を提供することで、服薬アドヒアランスを向上させることができます。さらに、テレヘルスは、患者がモバイル機器とモバイルヘルス技術を使用して、健康データを収集、入力、または自動的に収集し、医療提供者に伝えることを可能にし、在宅ケアのサブカテゴリである遠隔患者モニタリングを実現します。さらに、Mヘルスは投薬調整の精度を高め、ひいては患者の安全性を向上させます。例えば、Cureatr Meds 360ソリューションは、医療従事者やその他の臨床医に、患者が処方されたすべての薬について、入手や補充履歴、投与量の変更などを、iPhoneやAndroidの画面表示で分かりやすく提供します。

プライバシーとセキュリティのリスクは、世界のモバイルヘルス（mHealth）の成長を抑制します。

しかし、常にハッキングやデータの不一致の脅威があるため、セキュリティやプライバシーに関する懸念が予測期間中の世界市場の成長を阻害することになるでしょう。

COVID-19の影響分析

暴発の間、遠隔医療とバーチャルケアに注目が集まり、ウイルスに感染するリスクが常にあるパンデミックに対抗するために少し便利になり、世界市場の成長に大きな影響を与えました。例えば、Harward Global Health InstituteはCOVID-19予測モデルを作成し、COVID-19の患者、入院、ICU入室、人工呼吸器使用、死亡の早期警告システムを可能にし、医療従事者が積極的な姿勢で流行を食い止めるための行動を取れるようにしました。COVID-19の脅威が去った後も、バーチャル・ヘルスケア戦略は大きな利益をもたらすため、非常によく実践されています。

世界のモバイルヘルス（mHealth）レポートは、約40以上の市場データ表、45以上の図表、200ページ（概算）の範囲でのアクセスを提供することになります。

目次

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

• 市場インパクトファクター
  • 促進要因
    • 利点と利便性の提供
    • 認知度の向上
  • 阻害要因
    • プライバシーとセキュリティのリスク
  • ビジネスチャンス
  • 影響度分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 規制分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 サービス別

• フィットネス＆ウェルネスソリューション
• コンサルテーションサービス
• モニタリング
• 診断サービス
• 治療
• 予防

第8章 アプリケーション別

• 体温・温度モニター
• 血糖値モニター
• 心臓モニター
• 血行動態モニター
• 神経系モニター
• 遠隔患者モニタリング装置
• 呼吸器用モニター

第9章 エンドユーザー別

• ヘルスケアプロバイダー
• ヘルスケア消費者
• 公的・民間保険者
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク

第12章 企業プロファイル

• GE Healthcare
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• One Medical
• Apple
• OMADA Health
• Omron Healthcare
• LifeWatch
• Medtronics Plc
• Johnson & Johnson
• Samsung Healthcare Solutions
• AT&T
• Philips Healthcare
• Bayer Healthcare

第13章 DataM

Market Overview

Mobile Health Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY% during the forecast period (2022-2029).

Mobile health (mHealth) is a broad phrase for using mobile phones and other wireless technology in medical care. The most common application of mHealth is the use of mobile devices to educate consumers about preventive healthcare services.

Market Dynamics

Growing awareness about healthcare management, increasing use of smartphones and tablets owing to the benefits and convenience, and increasing focus on personalized medicine drive the global mHealth market.

The benefits and convenience offered by mobile health (mHealth) are pushing the market growth.

The benefits and convenience offered by mobile health are fueling the global market growth. For instance, mobile health technologies help patients quickly send secure messages, schedule appointments and connect 24/7 for telemedicine visits. In particular, telemedicine is among the fastest growing ways patients use mHealth apps on their mobile devices. It also improves medication adherence by providing patients with features such as automated medication and refills reminders and educational information that enhances the probability, they'll take their medications properly. Furthermore, telehealth enables patients to use mobile devices and mobile health technology to gather, enter, or automatically collect health data and convey it to healthcare providers, allowing remote patient monitoring, a subcategory of home care. Moreover, Mhealth improves medication reconciliation precision, that in turn improves patient safety example of which is the Cureatr Meds 360 solution offers providers and other clinicians a bird's-eye view of all medications a patient has been prescribed with pick up and refill history, dosage changes, and more on an uncluttered, iPhone or Android screen display.

Privacy and security risks will restrain global mobile health (mHealth) growth.

However, with the threat of constant hacking or data discrepancy, security and privacy concerns will hamper the global market growth in the forecast period.

COVID-19 Impact Analysis

During the outburst, there was an increased focus on telemedicine and virtual care, which made it a bit convenient to fight against the pandemic with the constant risk of getting infected with the virus, significantly impacting the global market growth. For example, Harward Global Health Institute created a COVID-19 forecasting model enabling an early alert system for COVID-19 cases, hospitalizations, ICU admissions, ventilator utilization, and deaths, allowing healthcare professionals to act with a proactive attitude in squelching the pandemic. Even after the threat of COVID-19 virtual healthcare strategy is highly practiced since it offers considerable benefits.

Segment Analysis

The monitoring services segment of mobile health (mHealth) is expected to grow at the fastest CAGR during the forecast period (2022-2029).

The monitoring services are expected to dominate the global market during the forecast period (2022-2029). Owing to the advantages and benefits offered by remote monitoring using smartphones since there are over three billion smartphone users worldwide, making it the most straightforward manner to reaching out to multitudes and remote areas, with smartphone technologies, wearable sensors, and smartphone platforms, remote monitoring the health/vitals of patients have become very easy and convenient. Resulting in preventive care, well-timed diagnosis, screening of ailments, and timely treatment, which in turn has reduced and will significantly reduce the number of hospital visits, and hospitalization, reducing hospital-induced infections. Collectively, all these benefits result in improving the quality of life. Furthermore, for effective patient care and safety, constant monitoring of physiological parameters is needed, which the technology's flexibility allows through real-time basis monitoring of the parameters in non-clinical environments such as home, office, park, traveling, Etc. and ease the communication of alerts/notifications to the healthcare professional, so urgent attention can be provided remotely in case of an emergency.

Geographical Analysis

The North America region will dominate the global mobile health (mHealth).

North America is expected to dominate the global market during the forecast period (2022-2029) since most of the key players in this market, such as one medical, GE Healthcare, Apple, OMADA Health, Medtronics Plc, Johnson & Johnson, AT&T are U.S. based and with different market, strategies have a hold over a large share of the market. For instance, in February 2022, Hartford HealthCare and One Medical Announce Collaboration Focused on Seamless Coordinated Care; in September 2021, One Medical acquired Iora Health, a human-centered, value-based primary care organization with built-for-purpose technology focused on serving the Medicare senior population.

Also, in April 2021, Omada Health Launched the First Virtual Cardiometabolic Clinic, a Physician-Guided Care Program; in May 2020, Omada Health Acquired Physera, a leading musculoskeletal care company that delivers interventions digitally and via telehealth.

Competitive Landscape

The key players operating in the global mobile health (mHealth) market are One Medical, GE Healthcare, Apple, OMADA Health, Omron Healthcare, LifeWatch, Medtronics Plc, Johnson & Johnson, Samsung Healthcare Solutions, AT&T, Philips Healthcare, and Bayer Healthcare. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of Mobile health (mHealth) globally. For instance, In January 2022, OMRON Healthcare, Inc. introduced VitalSight in the United States, Hypertension Plus in the U.K., and HeartVoice in Singapore to encourage more powerful active health condition management, boost the patient-physician association, and guide behavior change that reduces or eliminates heart attack and stroke risk.

GE Healthcare

Overview:

GE Healthcare is headquartered in Chicago, Illinois, United States, founded in 2004. It is a subsidiary of American Multinational Conglomerate General Electric. It is a leading manufacturer and distributor of diagnostic imaging and radiopharmaceuticals for imaging modalities used in medical imaging procedures.

Product Portfolio:

GE Healthcare's product portfolio for mHealth has Carestation Insights LIVE Mobile Application, Centricity Universal Viewer Zero Footprint, Vscan Extend Bladder Volume App, Vscan Extend Lung Protocol App, Vscan Extend Protocol Creator App, Etc.

The global mobile health (mHealth) report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Benefits and Convenience Offered
    • 4.1.1.2. Increased Awareness
  • 4.1.2. Restraints
    • 4.1.2.1. Privacy and Security Risks
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Service

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Segment
  • 7.1.2. Market Attractiveness Index, By Service Segment
• 7.2. Fitness & Wellness Solutions
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Consultation Services
• 7.4. Monitoring
• 7.5. Diagnostic
• 7.6. Treatment
• 7.7. Prevention

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.1.2. Market Attractiveness Index, By Application Segment
• 8.2. Body and Temperature Monitors
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Blood Glucose Monitors
• 8.4. Cardiac Monitors
• 8.5. Hemodynamic Monitors
• 8.6. Neurological Monitors
• 8.7. Remote Patient Monitoring Devices
• 8.8. Respiratory Monitors

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
  • 9.1.2. Market Attractiveness Index, By End-User Segment
• 9.2. Healthcare Providers
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Healthcare Consumers
• 9.4. Public & Private Insurers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
  • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. The U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
  • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. The U.K.
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Key Developments and Strategies
• 11.2. Company Share Analysis
• 11.3. Product Benchmarking

12. Company Profiles

• 12.1. GE Healthcare
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. One Medical
• 12.3. Apple
• 12.4. OMADA Health
• 12.5. Omron Healthcare
• 12.6. LifeWatch
• 12.7. Medtronics Plc
• 12.8. Johnson & Johnson
• 12.9. Samsung Healthcare Solutions
• 12.10. AT&T
• 12.11. Philips Healthcare
• 12.12. Bayer Healthcare

LIST NOT EXHAUSTIVE

13. DataM

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us